Home › Funds › Vivo Capital, LLC › CUE
Vivo Capital, LLC position in CUE
Cue Biopharma Inc · Health Care
Vivo Capital, LLC reported holding 280,057 shares of CUE (Cue Biopharma Inc) in its Q3 2026 13F filing — a position valued at US$7.2M, representing 0.82% of its reported portfolio and ranking #31 among its reported holdings. Vivo Capital, LLC first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Vivo Capital, LLC's CUE position evolved
Vivo Capital, LLC first disclosed a stake in CUE in Q3 2026 at 280,057 shares (US$7.2M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 280.06K | $7.25M | New |
About CUE and 13F data
CUE (Cue Biopharma Inc) is a Health Care company. 32 other funds we track also report a position in CUE — the largest reported positions include Bleichroeder LP (US$9.5M), Tetragon Partners GP Ltd (US$3.0M), Lion Point Capital, LP (US$1.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CUE
- Bleichroeder LP 366.15K sh · $9.47M · Q3 2026
- Tetragon Partners GP Ltd 93.82K sh · $2.96M · Q2 2026
- Lion Point Capital, LP 52.93K sh · $1.67M · Q2 2026
- Squadron Capital Management LLC 50.00K sh · $1.58M · Q2 2026
More on Vivo Capital, LLC
FAQ
How long has Vivo Capital, LLC held CUE?
Vivo Capital, LLC has disclosed CUE holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is Vivo Capital, LLC's current position in CUE?
As of Q3 2026, Vivo Capital, LLC holds 280.06K shares of CUE (Cue Biopharma Inc), valued at $7.25M, representing 0.82% of its reported portfolio and ranking #31.
Has Vivo Capital, LLC been buying or selling CUE?
In the latest 13F filing (Q3 2026), Vivo Capital, LLC newly opened its position in CUE.
Which other funds hold CUE?
Other major institutional holders of CUE include Bleichroeder LP, Tetragon Partners GP Ltd, Lion Point Capital, LP, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.